Patent ID: 7244749

Claim:
A method of lowering plasma concentration of a lipoprotein Lp(a) in a mammal, comprising administering to the mammal a composition of biochemical substances consisting essentially of ascorbic acid, ascorbyl palmitate, beta-, gamma-, delta-tocopherol-mix, beta-carotene, biotin, calcium ascorbate, calcium glycinate, α-carotene, lutein, zea-cryptoxanthin, cholecalciferol, chromium glycinate, citrus bioflavonoids, coenzyme Q 10, copper glycinate, cyanocobalamin, d-alpha-tocopherol, d-calcium pantothenate, dicalcium phosphate, folic acid, inositol, L-arginine, L-carnitine, L-cysteine, L-lysine, L-proline, L-seleonmethionine, magnesium ascorbate, magnesium glycinate, manganese chelate, molybdenum glycinate, niacin, niacinamide, potassium chelate, pycnogenol, pyridoxine, riboflavin, thiamine, and zinc glycinate, wherein the composition is in therapeutically effective amounts to lower the plasma concentration of the lipoprotein Lp(a) in a mammal.